61 filings
Page 3 of 4
8-K
1im5h
15 Nov 21
Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
k5ojegec57fdjh2e4
29 Sep 21
U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older
4:42pm
8-K
rlp854t0
20 Aug 21
Mirum Pharmaceuticals Appoints Biotechnology Executive William C. Fairey to its Board of Directors
12:00am
8-K
z9btn3et25
5 Aug 21
Mirum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
4:36pm
8-K
l6biv4nyb 2tgp0f93xi
9 Jun 21
Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors
4:17pm
8-K
9f1a wbktluxvzuc723
6 May 21
Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
lqck4dm
29 Mar 21
Other Events
4:17pm
8-K
yc4ay2q
9 Mar 21
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Results and Provides Business Updates
4:05pm
8-K
4xn41xy5ay
12 Jan 21
Mirum Pharmaceuticals Provides Corporate Update
9:10am
8-K
s575fztxu3tvn3xd
15 Dec 20
Other Events
5:09pm
8-K
jylon
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
8-K
avfzk
12 Nov 20
Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor Day
6:06am
8-K
nv0w2mpfqpdwlqu
6 Aug 20
Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
4:05pm
8-K
9uo g9nj28ffolh8z3n
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
iek7dk985zmhf unp7jv
7 May 20
Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Updates
4:06pm
8-K
x2bz3xe z3jcq4k081
12 Mar 20
Mirum Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
t5qpht3qu
14 Jan 20
Departure of Directors or Certain Officers
4:00pm
8-K
lvs5zp h6
27 Dec 19
Departure of Directors or Certain Officers
4:15pm
8-K
i93x7 ttj0i0
6 Nov 19
Mirum Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
4:05pm
8-K
coo1ine1uzmzcxb rz1
28 Aug 19
Mirum Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
4:07pm